Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54,093,000 | $50,625,000 | $59,561,000 | $61,025,000 |
| Short-Term Investments | $15,992,000 | $14,699,000 | $14,699,000 | $13,599,000 |
| Receivables | $21,178,000 | $23,744,000 | $19,268,000 | $20,260,000 |
| Inventory | $19,020,000 | $17,167,000 | $15,563,000 | $14,980,000 |
| Other Curr. Assets | $1,094,000 | $739,000 | $812,000 | $749,000 |
| Total Curr. Assets | $111,377,000 | $106,974,000 | $109,903,000 | $110,613,000 |
| Property Plant & Equip (Net) | $27,629,000 | $25,355,000 | $25,498,000 | $25,734,000 |
| Goodwill | $14,035,000 | $0 | $0 | $0 |
| Intangibles | $5,254,000 | $7,462,000 | $6,741,000 | $8,236,000 |
| Long-Term Investments | $0 | $5,833,000 | $20,312,000 | $18,871,000 |
| Tax Assets | $4,065,000 | $2,590,000 | $3,873,000 | $1,725,000 |
| Other NC Assets | $28,060,000 | $23,406,000 | -$1,000 | -$1,000 |
| Total NC Assets | $79,043,000 | $64,646,000 | $56,423,000 | $54,565,000 |
| Other Assets | $2,000 | $3,000 | $2,000 | $3,000 |
| Total Assets | $190,422,000 | $171,623,000 | $166,328,000 | $165,181,000 |
| Liabilities | – | – | – | – |
| Payables | $8,186,000 | $6,976,000 | $6,219,000 | $5,939,000 |
| Short-Term Debt | $3,850,000 | $3,850,000 | $3,850,000 | $3,850,000 |
| Tax Payable | $7,285,000 | $76,000 | $2,004,000 | $2,436,000 |
| Deferred Revenue | $0 | $0 | $9,389,000 | $7,373,000 |
| Other Curr. Liab. | $11,033,000 | $8,122,000 | $8,765,000 | $6,824,000 |
| Total Curr. Liab. | $30,354,000 | $19,024,000 | $20,838,000 | $19,049,000 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1,514,000 | $1,947,000 | $1,771,000 | $2,229,000 |
| Other NC Liab. | $5,920,000 | $6,897,000 | $6,884,000 | $5,580,000 |
| Total NC Liab. | $7,434,000 | $8,844,000 | $8,655,000 | $7,809,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $37,788,000 | $27,868,000 | $29,493,000 | $26,858,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $23,853,000 | $23,853,000 | $23,853,000 | $23,853,000 |
| Retained Earnings | $135,242,000 | $128,506,000 | $126,135,000 | $126,347,000 |
| AOCI | $0 | $0 | $4,889,000 | $0 |
| Other Equity | -$6,461,000 | -$8,604,000 | -$18,620,000 | -$12,455,000 |
| Total Equity | $152,634,000 | $143,755,000 | $136,257,000 | $137,745,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $578,000 | $578,000 |
| Total Liab. & Tot. Equity | $190,422,000 | $171,623,000 | $166,328,000 | $165,181,000 |
| Net Debt | -$50,243,000 | -$46,775,000 | -$55,711,000 | -$57,175,000 |